Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jonsson Comprehensive Cancer Center
University of Pennsylvania
University Hospital, Basel, Switzerland
Mayo Clinic
First Affiliated Hospital of Fujian Medical University
National Cancer Institute (NCI)
Boston Pharmaceuticals
Azienda Ospedaliero, Universitaria Pisana
Vanderbilt-Ingram Cancer Center
Sanofi
SWOG Cancer Research Network
National Cancer Institute (NCI)
University of Southern California
Duke University
National Cancer Institute (NCI)
Exelixis
Duke University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Case Comprehensive Cancer Center